Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation.
C. B. Schroeter, C. Nelke, M. Schewe, L. Spohler, A. M. Herrmann, T. Müntefering, N. Huntemann, M. Kuzikov, P. Gribbon, S. Albrecht, S. Bock, P. Hundehege, L. C. Neelsen, T. Baukrowitz, G. Seebohm, B. Wünsch, S. Bittner, T. Ruck, T. Budde, S. G. Meuth
Research article (journal) | Peer reviewedDetails about the publication
Journal: Biological Chemistry
Volume: 404
Issue: 4
Page range: 355-375
Status: Published
Release year: 2023
Language in which the publication is written: English
Keywords: BL-1249; blood-brain barrier; electrophysiology; K2P channels; TREK1; TRESK.
Authors from the University of Münster
| Wünsch, Bernhard | Professur für Pharmazeutische Chemie (Prof. Wünsch) |